|

The Formulation Design & Development Section is comprised of members from many diverse
backgrounds in industry, regulatory and academia who share a common interest in
the area of formulation design, research and development - a multidisciplinary field
drawing upon the physical, chemical, biological and engineering sciences. The primary
goal of this section is to unite multiple scientific disciplines in a forum where
they can share experimental results, consider new formulation and dosage form technologies,
and discuss issues and concerns regarding the design and development of formulations/drug
products for all dosage forms. This Section collaboratively interfaces with other
sections which focus on pre-formulation, biopharmaceutics, formulation strategies,
and manufacturing process optimization.
Aspects of formulation design and development include the study of dosage forms
for drug delivery via all routes of administration wherein the dosage form encompasses
the formulation, process by which it is made, and primary packaging. The Section’s
focus on development includes product design, delivery systems and technology, stability,
quality, and performance both in vitro and in vivo that is appropriate to its development
stage.
Section Vision
The Formulation Design and Development Section will be the premier worldwide forum
for scientists dedicated to the design and development of all dosage forms.
Section Mission
The Formulation Design and Development Section provides a dynamic international
forum for the exchange of formulation-related knowledge among scientists to enhance
their contributions to health. We offer timely formulation-related scientific programs,
on-going education, opportunities for networking, and professional development by:
- Providing forums for the free interchange and dissemination of scientific knowledge,
particularly in the area of formulation design and development;
- Fostering the scientific and technical growth of scientists in the discipline;
- Promoting and recognizing excellence in the discipline;
- Encouraging the support of basic academic, industrial, and regulatory research programs
and the development of mutually beneficial relationships;
- Encouraging students to enter the discipline by strengthening and increasing the
viability of academic programs in formulation design and development;
- Collaborating with and supporting other AAPS sections, focus groups, and other professional/scientific
organizations; and
- Informing the public of major advances in formulation design and development.
FIP Pharmaceutical Sciences World Congress 2010 in association with the AAPS Annual Meeting & Exposition
FDD Programming
Program-at-a-Glance
Meeting Website
Meeting Registration
Registration rates increase after September 10, 2010.
Housing Reservations
Hotel Reservation Deadline: October 22, 2010
Volunteer for the FDD Section Booth (Coming Soon)
Formulation Design and Development Headlines
FDA Puts Brakes on Roche, ImmunoGen Cancer Drug Reuters (08/27/10) de Sa'Pinto, Martin; Reid, Katie AAPS Announces Results of 2010 Election AAPS Press Release (08/24/2010) Orphan Drug Research Suddenly in Vogue eCliniqua (08/16/10) Borfitz, Deb Molecular Bandit Keeps Pain at Bay Newswise (08/02/10) Robot Pills Scientific American (08/10) Vol. 303, No. 2, P. 62; Dario, Paolo; Menciassi, Arianna Human Clinical Trial of NIH-Developed Dengue Vaccine Begins NIH News Release (08/09/10) Adipose Stem Cell Developments Overseas Open New Doors for Cosmetic Surgery Modern Medicine (08/01/10) Nataloni, Rochelle Meeting Highlights From the Committee for Medicinal Products for Human Use (CHMP) European Medicines Agency (07/23/2010) Nano-Patch to Replace Needles for Vaccination Soon: Study News-Medical.Net (07/26/2010) Mandal, Ananya Multifunctional Nanoparticles as Coupled Contrast Agents Nature Communications (07/27/10) Jun, Yongdong; Jia, Congxian; Huang, Sheng-Wen; et al. Dissolving Polymer Microneedle Patches for Influenza Vaccination Nature Medicine (07/10) Sullivan, Sean P.; Koutsonanos, Dimitrios G.; Martin, Maria del Pilar; et al. Statement of Anthony S. Fauci, M.D. Director, National Institute of Allergy and Infectious Diseases National Institutes of Health... NIH News Release (07/20/10) Should Birth-Control Pill Be Sold Without a Prescription? Newsweek (07/07/10) Melnick, Meredith Crucell Starts Work on RSV Vaccine Reuters (06/24/10) Gay-Block, Aaron Botox May Affect Ability to Feel Emotions WebMD (06/23/10) Mann, Denise Tremendously Successful AAPS Webinar Series on ADME and Pharmacokinetics in Drug Discovery/Development to Present Third Installment AAPS Press Release (06/29/2010) Stem Cells Used to Create Cells to Study Heart Condition National Institutes of Health - Research Matters (06/21/2010) Wein, Harrison FDA Wants More Info on GlaxoSmithKline Vaccine MenHibrix Triangle Business Journal (06/14/10) Gallagher, James
|
Chair Dr. Colin M. Minchom, Ph.D. Patheon Inc. Mississauga, ON Canada
| Chair-Elect Dave Wallick, Ph.D. The Dow Chemical Company Midland, MI UNITED STATES
| Vice Chair Dr. Samantha Lai, Ph.D. Tamlylin Mountain View, CA United States
| Secretary/Treasurer Lori R. Hilden, Ph.D. Eli Lilly & Company Indianapolis, IN
| Past Chair Dr. Mansoor A. Khan, R.Ph., Ph.D. FDA/CDER/DPQR, HFD-941 Silver Spring, MD UNITED STATES
| Member at Large Dr. David Y. Mitchell, Ph.D. Mitchell Pharmaceutical Consulting, LLC Lafayette, CO United States
| Annual Meeting Program Committee Dave Wallick, Ph.D. The Dow Chemical Company Midland, MI UNITED STATES
| Annual Meeting Screeners Committee Jayanth Panyam University of Minnesota Minneapolis, MN UNITED STATES
| Content Advisory Committee Joseph P. Reo, Ph.D. Merck Consumer Care Memphis, TN
| Fellows Committee Dr. Mansoor A. Khan, R.Ph., Ph.D. FDA/CDER/DPQR, HFD-941 Silver Spring, MD UNITED STATES
| Membership Strategic Oversight Committee Dr. Rakhi B. Shah, Ph.D. FDA/CDER/DPQR Silver spring, MD United States
| National Biotech Conf Program Committee Dr. Feroz Jameel Amgen Thousand Oaks, CA
| National Biotechnology Conference Screeners Committee Yoon Yeo Purdue University West Lafayette, IN United States
| Nominations Committee Dr. Colin M. Minchom, Ph.D. Patheon Inc. Mississauga, ON Canada
| Program Coordination Committee Dave Wallick, Ph.D. The Dow Chemical Company Midland, MI UNITED STATES
| Student/PostDoc Outreach & Develp Committee Bhaskara R. Jasti, Ph.D. University of the Pacific Stockton, CA United States
| Awards Committee Dr. Kenneth R. Morris, Ph.D. University of Hawaii at Hilo Hilo, HI
| Communications Committee Naveen K. Bejugam, Ph.D. SRI International Menlo Park, CA United States
| Finance Committee Mrs. Karen Coppens, MBA Dow Chemical Co. Midland, MI
| Finance Committee Dr. Anil Kane, Ph.D. Patheon, Inc. Mississauga, ON Canada
| Programming Committee Bhaskara R. Jasti, Ph.D. University of the Pacific Stockton, CA United States
| Webmasters Committee Naveen K. Bejugam, Ph.D. SRI International Menlo Park, CA United States
| Strategic Planning Otilia M. Koo, Ph.D. Bristol-Myers Squibb Company New Brunswick, NJ United States
| Strategic Planning Indra K. Reddy, Ph.D. Texas A&M Health Science Center College of Pharmacy Kingsville, TX United States
| Student Rep Mr. Ravikanth Kona University of Maryland Baltimore, MD United States
| Staff Liaison Maria Nadeau AAPS Arlington, VA United States
| Staff Liaison Sharon R. Pichon AAPS Arlington, VA
| Staff Liaison Grace Jones AAPS Arlington, VA
|
|